Skip to Content

Vendors


Vendors

Resmed CEO: ‘We began fiscal year 2027 with a strong first quarter’

October 29, 2026HME News Staff

SAN DIEGO – Resmed reported revenue increased 6% to $1.4 billion in the first quarter of fiscal year 2027. On a core constant currency basis, Americas Sleep and Breathing Health revenue grew 7%, Rest of World Sleep and Breathing Health grew 8% and Residential Care Software revenue increased 5%. “We began fiscal year 2027 with a strong first quarter, driven by continued global demand for our sleep and breathing health solutions and ongoing execution across our business,” said...

CPAP Therapy, First Quarter (Q1), fiscal year 2027, ResMed


Read Full Articlered right arrow icon

Vendors

Medline updates use instructions for Medline brand beds

October 26, 2026HME News Staff

NORTHFIELD, Ill. – Medline has updated its Oct. 14, 2026, communication regarding the product removal, market exit and discontinuation of Medline Brand beds, rails, mattresses and accessories to include revised instructions for continued use and a new repair option. The company says customers can continue to use Medline Brand beds, rails, mattresses and accessories, in accordance with the revised instructions.  “In an effort to support continuity of care and to minimize disruptions...

market exit, Medline, Medline brand beds, Recall, refund


Read Full Articlered right arrow icon

Peter Loope

Vendors

Manufacturers race to fill gap following Medline exit

October 23, 2026Liz Beaulieu, Editor

YARMOUTH, Maine – Medline’s decision to voluntarily recall all Medline-brand beds and exit that market has triggered a scramble among manufacturers and home medical equipment (HME) providers, creating what’s expected to be months of elevated demand and potential supply constraints. The company's exit applies to home care, bariatric and long-term care beds, as well as associated pendants, accessories, replacement parts and bed-containing order packages. Medline has not...

Demand, home care beds, market exit, Medline, Recall


Read Full Articlered right arrow icon

Vendors

Fisher & Paykel Healthcare reports cyber incident

October 22, 2026HME News Staff

AUCKLAND, New Zealand – Fisher & Paykel Healthcare has been made aware of unauthorized and unlawful access to two employee email accounts and a subset of company files. The company says it immediately activated its response protocols to contain the incident and investigate the nature and extent of the activity. “There has been no impact to the company’s products, manufacturing operations or supply chain, and its ability to supply and support customers and patients continues...

CPAP, Cyberattack, Fisher & Paykel Healthcare


Read Full Articlered right arrow icon

Vendors

ABM raises $20M, injecting capital & flexibility into growth strategy

October 21, 2026HME News Staff

EAGAN, Minn. – ABM Respiratory Care has obtained a $20 million growth capital commitment from Trinity Capital, an international alternative asset manager. ABM says the financing will support its next phase of growth, with a focus on accelerating commercial expansion, strengthening its presence in existing and new markets, and advancing product innovation, clinical research and connected respiratory care technologies. "This financing represents an important milestone in ABM Respiratory...

ABM Respiratory Care, BiWaze, home respiratory care, Trinity Capital


Read Full Articlered right arrow icon

Vendors

Medline executes field action, prepares to exit bed market

October 19, 2026HME News Staff

NORTHFIELD, Ill. – Medline is executing a voluntary field action to initiate product removal, discontinuation and market exit of all Medline brand beds, including home care, bariatric and long-term care beds, the company announced in an Oct. 14 letter to customers. The exit also applies to all associated pendants, accessories, replacement parts and bed-containing order packages, the company says. “We believe this action best supports our commitment to product quality and safety...

Hospital bed, market exit, Medline, voluntary recall


Read Full Articlered right arrow icon

Vendors

Resmed discontinues Astral ventilator portfolio

October 19, 2026HME News Staff

SAN DIEGO – Resmed discontinued new sales of its Astral ventilator portfolio effective Sept. 14, 2026, according to a letter to customers. The company says the decision allows it to prioritize available components and resources toward existing patients and continuity of care, following a field safety corrective action (FSCA). “Ongoing supply constraints affecting critical electronic components have created significant challenges for the continued manufacture of Astral ventilators,”...

Astral, field safety notice, ResMed, ventilators


Read Full Articlered right arrow icon

Carlos Nunez

Vendors

Eight Sleep, Resmed partner to increase understanding of sleep health

October 19, 2026HME News Staff

NEW YORK and SAN DIEGO – A new partnership will bridge technology from Eight Sleep with sleep insights from Resmed, helping people in the United States and Australia better understand their sleep health, the companies say. As part of the collaboration, Resmed has also made an investment in Eight Sleep. “At Eight Sleep, we’re focused on transforming the bed and bedroom into a preventative and predictive health platform,” said Matteo Franceschetti, co-founder and CEO of...

CPAP Device, Eight Sleep, myAir, ResMed


Read Full Articlered right arrow icon

Vendors

Trace Medical acquires major stake in Liviliti

October 13, 2026HME News Staff

WHITMORE LAKE, Mich. & SARASOTA, Fla. – Trace Medical has acquired a majority interest in LiViliti Health Products, Inc. The acquisition follows LiViliti receiving 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Paptizer 360 classified as a Class II Respiratory Accessory Microbial Reduction Device for CPAP equipment. The acquisition builds upon the existing strategic investment between the two organizations, aligning Trace Medical’s expansive nationwide distribution...

Home Respiratory Equipment, Liviliti Health Products, Trace Medical


Read Full Articlered right arrow icon

Brian Tyler

Vendors

McKesson, CD&R to buy Option Care for 37% premium

October 6, 2026HME News Staff

NEW YORK and IRVING, Texas – McKesson and CD&R will acquire Option Care Health for $32.05 per share, reflecting a total enterprise value of $5.8 billion. CD&R will hold a majority stake, and McKesson will hold a minority stake. The transaction value represents a premium of about 37% to Option Care Health’s closing share price on Oct. 5, 2026, the last full trading day of the company’s common stock prior to the announcement. In line with McKesson’s strategic objectives The...

Clayton, Dubilier & Rice (CD&R), Home Infusion, McKesson, Mergers & Acquisitions (M&A), Option Care Health


Read Full Articlered right arrow icon